(NASDAQ: GDRX) Goodrx Holdings's forecast annual revenue growth rate of 3.83% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 11.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.54%.
Goodrx Holdings's revenue in 2023 is $737,730,000.On average, 8 Wall Street analysts forecast GDRX's revenue for 2023 to be $303,935,753,516, with the lowest GDRX revenue forecast at $301,999,722,482, and the highest GDRX revenue forecast at $306,974,838,943. On average, 8 Wall Street analysts forecast GDRX's revenue for 2024 to be $317,684,944,754, with the lowest GDRX revenue forecast at $314,342,072,624, and the highest GDRX revenue forecast at $330,018,766,126.
In 2025, GDRX is forecast to generate $336,259,795,894 in revenue, with the lowest revenue forecast at $326,002,121,081 and the highest revenue forecast at $345,455,841,774.